Page last updated: 2024-09-02

3,5-dihydroxyphenylglycine and Autosomal Dominant Cerebellar Ataxia, Type II

3,5-dihydroxyphenylglycine has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bezprozvanny, I; Herndon, E; Huynh, DP; Liu, J; Nelson, O; Pulst, SM; Tang, TS; Tu, H1

Other Studies

1 other study(ies) available for 3,5-dihydroxyphenylglycine and Autosomal Dominant Cerebellar Ataxia, Type II

ArticleYear
Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Jul-22, Volume: 29, Issue:29

    Topics: Animals; Ataxins; Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Death; Cells, Cultured; Chlorocebus aethiops; COS Cells; Dantrolene; Excitatory Amino Acid Agents; Glutamic Acid; Glycine; Inositol 1,4,5-Trisphosphate Receptors; Mice; Mice, Transgenic; Motor Activity; Nerve Degeneration; Nerve Tissue Proteins; Purkinje Cells; Resorcinols; Ryanodine; Spinocerebellar Ataxias

2009